Home > Financial Ratios > SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
SUVEN PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
AD     Remove this Ad

SUVEN PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -7.26-24.63-7.9547.4313.49

What is the latest Core EBITDA Growth ratio of SUVEN PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of SUVEN PHARMACEUTICALS is -7.26 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-7.26
Mar2024-24.63
Mar2023-7.95
Mar202247.43
Mar202113.49

How is Core EBITDA Growth of SUVEN PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 -7.26
Negative
Mar2024 -24.63
Negative
Mar2023 -7.95
Negative
Mar2022 47.43
251.59
Mar2021 13.49 -

Other Financial Ratios of SUVEN PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of SUVEN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS ₹12,985.4 Cr -8.5% -32.7% -67.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,615.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹159,943.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,336.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹107,499.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,590.0 Cr 5% -0.1% 3.3% Stock Analytics


SUVEN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS

-8.5%

-32.7%

-67.8%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses